Evaluation of commercially available immuno‐magnetic agglutination in comparison to enzyme‐linked immunosorbent assays for rapid point‐of‐care diagnostics of COVID‐19

INTRODUCTION: Coronavirus disease 2019 (COVID‐19) is caused by Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Fast, accurate, and simple blood‐based assays for quantification of anti‐SARS‐CoV‐2 antibodies are urgently needed to identify infected individuals and keep track of the sprea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Virol
Main Authors: Moeller, Maria E., Fock, Jeppe, Pah, Pearlyn, Veras, Antia De La C., Bade, Melanie, Donolato, Marco, Israelsen, Simone B., Eugen‐Olsen, Jesper, Benfield, Thomas, Engsig, Frederik N.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013206/
https://ncbi.nlm.nih.gov/pubmed/33547818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26854
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados